Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...

The stock of Zydus Lifesciences has been in a steady decline since August last year after facing resistance at ₹1,300. After witnessing some consolidation between ₹940 and ₹1,000 in December ...

She shared the news in a statement on Instagram beside a photo of her visiting a cancer patient at the Royal Marsden Hospital, where the royal was also treated and now holds the title of joint ...

In the same year, the company signed a 50:50 joint venture with Mayne Pharma of Australia to manufacture generic injectable, cytotoxic (anti-cancer ... the merger of Zydus Hospital and Medical ...

Mar. 12, 2025 — Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive ...

Reel it in, Cancer. If you’ve overextended and overcommitted (again), you’ll have a chance to graciously bow out of a few non-mandatory situations this Wednesday, March 12 (AKA “the Day of ...

THE GOOD KARMA HOSPITAL tells the story of junior doctor, Ruby Walker, who arrives in India looking for a job and a distraction from her heartbreak. She anticipates the sunshine, the palm trees ...

Nippon India Small Cap Fund - Direct (IDCW) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct (G) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct ...

Browse 30+ cartoon of breast cancer logos stock illustrations and vector graphics available royalty-free, or start a new search to explore more great stock images and vector art. Woman used shield ...

Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.